Argent Trust’s AstraZeneca AZN Stock Holding History

Argent Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$484K	Sell	6,924 -1,060	-13%	-$73.4K	0.13%	142
2017 Q4	$554K	Buy	7,984 +85	+1%	+$5.73K	0.15%	125
2017 Q3	$535K	Buy	7,899 +1,843	+30%	+$116K	0.15%	128
2017 Q2	$413K	Sell	6,056 -18	-0.3%	-$1.18K	0.12%	147
2017 Q1	$378K	Buy	+6,074	New	+$354K	0.11%	155
2016 Q4	–	Sell	-3,337	Closed	-$219K	–	202
2016 Q3	$219K	Buy	+3,337	New	+$218K	0.07%	195

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Argent Trust's AZN Position: Q1 2018 in Review

Argent Trust reduced its AstraZeneca (AZN) stake by 13% in Q1 2018, selling an estimated $73.4K and leaving 6,924 shares worth $484K. The position accounts for 0.13% of the portfolio, ranked #142.

Argent Trust first reported a position in AZN in Q3 2016 and has held it in 6 quarters since. The position peaked at $554K in Q4 2017. 518 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

Argent Trust held 6,924 shares of AstraZeneca worth $484K as of Q1 2018.
Argent Trust sold 1,060 AstraZeneca shares in Q1 2018, an estimated $73.4K.
AstraZeneca made up 0.13% of Argent Trust's portfolio in Q1 2018, its #142 holding.
Argent Trust first reported a position in AstraZeneca in Q3 2016 and has held it in 6 quarters since.
Argent Trust's AstraZeneca position peaked at $554K in Q4 2017.
518 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.